Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type iii. (A literature review of perioperative management of patients with hereditary angioedema type iii);Uso profiláctico de icatibant en un caso de angioedema hereditario tipo iii. (Revisión de la literatura sobre manejo perioperatorio en pacientes con angioedema hereditario tipo iii)

Revista Espanola de Anestesiologia y Reanimacion

Volumn 61, Issue 7, 2014, Pages 375-381

  Iturri Clavero, F ^a   Gonzalez Uriarte A ^a   Tamayo Medel, G ^a,b   Gamboa Setien P M ^c  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

Author keywords

Anesthesia; Hereditaryangioedema type iii; Icatibant; Intubation

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CHLORPHENIRAMINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE; ICATIBANT; RANITIDINE;

ADULT; AIRWAY OBSTRUCTION; ANALOGS AND DERIVATIVES; ANGIONEUROTIC EDEMA; ARTIFICIAL VENTILATION; BREAST TUMOR; CARCINOMA, DUCTAL, BREAST; CASE REPORT; CEREBELLAR NEOPLASMS; COMPLICATION; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; LARYNGEAL EDEMA; PATHOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SECONDARY; TRACHEOSTOMY;

ADULT; AIRWAY OBSTRUCTION; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONISTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CEREBELLAR NEOPLASMS; CHLORPHENIRAMINE; DEXAMETHASONE; FEMALE; HEREDITARY ANGIOEDEMA TYPE III; HUMANS; INTUBATION, INTRATRACHEAL; LARYNGEAL EDEMA; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREANESTHETIC MEDICATION; RANITIDINE; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS; TRACHEOSTOMY;

EID: 84904063058     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2014.01.011     Document Type: Short Survey

References (37)

1. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 2010, 6:15.
2. Levy J.H., Freiberger D.J., Roback J. Hereditary angioedema: Current and emerging treatment options. Anesth Analg 2010, 110:1271-1280.
3. Yazawa T., O'higashi T., Daijo H., Shinomura T. Anesthesia management for emergency laparotomy in a pediatric patient with suspected hereditary angioedema. J Anesth 2010, 24:121-123.
4. Bowen T., Cicardi M., Farkas H., Bork K., Longhurst H.J., Zuraw B., et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010, 6:24.
5. Bork K., Barnstedt S.E., Koch P., Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
6. Valero R., Mayoral V., Massó E., López A., Sabaté S., Villalonga R., et al. Evaluation and management of expected or unexpected difficult airways: Adopting practice guidelines. Rev Esp Anestesiol Reanim 2008, 55:563-570.
7. Bork K., Staubach P., Eckardt A.J., Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006, 101:619-627.
8. Bork K., Gül D., Dewald G. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol 2006, 154:542-545.
9. Bork K., Gül D., Hardt J., Dewald G. Hereditary angioedema with normal C1 inhibitor: Clinical symptoms and course. Am J Med 2007, 120:987-992.
10. Agostoni A., Aygören-Pürsün E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004, 114(3 Suppl):S51-S131.
11. Kaplan A.P., Greaves M.W., Angioedema J Am Acad Dermatol 2005, 53:373-388. quiz 389-392.
12. Marmarou A., Guy M., Murphey L., Roy F., Layani L., Combal J.P., et al. A single dose, three-arm, placebo-controlled, phase i study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury. J Neurotrauma 2005, 22:1444-1455.
13. Narotam P.K., Rodell T.C., Nadvi S.S., Bhoola K.D., Troha J.M., Parbhoosingh R., et al. Traumatic brain contusions: A clinical role for the kinin antagonist CP-0127. Acta Neurochir (Wien) 1998, 140:793-802. discussion 802-793.
14. Thornton E., Ziebell J.M., Leonard A.V., Vink R. Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules 2010, 15:6598-6618.
15. Sunder T.R., Balsam M.J., Vengrow M.I. Neurological manifestations of angioedema. Report of two cases and review of the literature. JAMA 1982, 247:2005-2007.
16. Decloedt E., Freercks R., Maartens G. Cerebral angioedema associated with enalapril. Br J Clin Pharmacol 2009, 68:271-273.
17. Bork K., Meng G., Staubach P., Hardt J. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 2006, 119:267-274.
18. Banerji A. Hereditary angioedema: Classification, pathogenesis, and diagnosis. Allergy Asthma Proc 2011, 32:403-407.
19. Caballero T., Baeza M.L., Cabañas R., Campos A., Cimbollek S., Gómez-Traseira C., et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 2011, 21:422-441. quiz 442-423.
20. Stojiljkovic L. Renin-angiotensin system inhibitors and angioedema: Anesthetic implications. Curr Opin Anaesthesiol 2012, 25:356-362.
21. Andrew N., Gabb G., del Fante M. ACEI associated angioedema - A case study and review. Aust Fam Physician 2011, 40:985-988.
22. Haymore B.R., Yoon J., Mikita C.P., Klote M.M., DeZee K.J. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: A meta-analysis. Ann Allergy Asthma Immunol 2008, 101:495-499.
23. Bork K., Fischer B., Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003, 114:294-298.
24. Borradori L., Marie O., Rybojad M., Vexiau P., Morel P., Späth P. Hereditary angioedema and oral contraception. Dermatologica 1990, 181:78-79.
25. Bouillet L., Ponard D., Drouet C., Jullien D., Massot C. Angioedema and oral contraception. Dermatology 2003, 206:106-109.
26. Farkas H., Zotter Z., Csuka D., Szabó E., Nébenfuhrer Z., Temesszentandrási G., et al. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--A long-term survey. Allergy 2012, 67:1586-1593.
27. Majluf-Cruz A., Nieto-Martínez S. Long-term follow up analysis of nadroparin for hereditary angioedema. A preliminary report. Int Immunopharmacol 2011, 11:1127-1132.
28. Caldwell E.E., Andreasen A.M., Blietz M.A., Serrahn J.N., VanderNoot V., Park Y., et al. Heparin binding and augmentation of C1 inhibitor activity. Arch Biochem Biophys 1999, 361:215-222.
29. Frank M.M. Hereditary angioedema. J Allergy Clin Immunol 2008, 121(2 Suppl):S398-S401. quiz S419.
30. Wall R.T., Frank M., Hahn M. A review of 25 patients with hereditary angioedema requiring surgery. Anesthesiology 1989, 71:309-311.
31. Bouillet L., Boccon-Gibod I., Ponard D., Drouet C., Cesbron J.Y., Dumestre-Perard C., et al. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type iii attacks. Ann Allergy Asthma Immunol 2009, 103:448.
32. Iturri Clavero F., Honorato C., Ingelmo Ingelmo I., Fàbregas Julia N., Rama-Maceiras P., Valero R.R., et al. Consideraciones preoperatorias y manejo neuroanestesiológico preoperatorio. Rev Esp Anestesiol Reanim 2012, 59(Supl 1):3-24.
33. Jensen N.F., Weiler J.M. C1 esterase inhibitor deficiency, airway compromise, and anesthesia. Anesth Analg 1998, 87:480-488.
34. Szema A.M., Paz G., Merriam L., Stellaccio F., Jen J. Modern preoperative and intraoperative management of hereditary angioedema. Allergy Asthma Proc 2009, 30:338-342.
35. Bork K., Wulff K., Hardt J., Witzke G., Staubach P. Hereditary angioedema caused by missense mutations in the factor xii gene: Clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009, 124:129-134.
36. Ochoa M.E., Marín Mdel C., Frutos-Vivar F., Gordo F., Latour-Pérez J., Calvo E., et al. Cuff-leak test for the diagnosis of upper airway obstruction in adults: A systematic review and meta-analysis. Intensive Care Med 2009, 35:1171-1179.
37. Bauman KA, Hyzy RC. Extubation management. Up to date. 2010.